Abstract
BackgroundBiological therapy, especially anti-tumor necrosis factor alpha, increases the risk of reactivation of latent tuberculosis (TB) infection in patients with rheumatoid arthritis (RA) (1). The influence of the underlying RA...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have